{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:34:06Z","timestamp":1792953246082,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR24\/00025"],"award-info":[{"award-number":["JR24\/00025"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s13555-026-01924-6","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:41:18Z","timestamp":1790311278000},"page":"5567-5581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["48-Week Real-World Atopic Dermatitis Study on Minimal Disease Activity, Associated Factors, and Agreement Between Clinician- and Patient-Reported Outcomes"],"prefix":"10.1007","volume":"16","author":[{"given":"Andrea I.","family":"Rodriguez-Sanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garc\u00eda-Moronta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Castro-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara A.","family":"Ure\u00f1a-Paniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Arias-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"Montero-Vilchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"12","key":"1924_CR1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3510","volume":"100","author":"L Kobyletzki","year":"2020","unstructured":"Kobyletzki L, Svalstedt M, Svensson A. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol. 2020;100(12):adv00160. https:\/\/doi.org\/10.2340\/00015555-3510.","journal-title":"Acta Derm Venereol"},{"issue":"S3","key":"1924_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-024-00927-2","volume":"20","author":"S Carr","year":"2024","unstructured":"Carr S, Pratt R, White F, Watson W. Atopic dermatitis. Allergy Asthma Clin Immunol. 2024;20(S3):63. https:\/\/doi.org\/10.1186\/s13223-024-00927-2.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"1924_CR3","doi-asserted-by":"publisher","unstructured":"Birdi G, Cooke R, Knibb RC. Impact of atopic dermatitis on quality of life in adults: a systematic review and meta\u2010analysis. Int J Dermatol. 2020;59(4). https:\/\/doi.org\/10.1111\/ijd.14763","DOI":"10.1111\/ijd.14763"},{"issue":"9","key":"1924_CR4","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/jdv.18345","volume":"36","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg A, Kinberger M, Arents B, Aszodi N, Avila Valle G, Barbarot S, et al. European guideline (EuroGuiDerm) on atopic eczema: part I \u2013 systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409\u201331. https:\/\/doi.org\/10.1111\/jdv.18345.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"1924_CR5","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1111\/jdv.20639","volume":"39","author":"A Wollenberg","year":"2025","unstructured":"Wollenberg A, Kinberger M, Arents B, Aszodi N, Barbarot S, Bieber T, et al. European guideline (EuroGuiDerm) on atopic eczema: living update. J Eur Acad Dermatol Venereol. 2025;39(9):1537\u201366. https:\/\/doi.org\/10.1111\/jdv.20639.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1924_CR6","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.jaad.2023.08.102","volume":"90","author":"DMR Davis","year":"2024","unstructured":"Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, et al. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. J Am Acad Dermatol. 2024;90(2):e43-56. https:\/\/doi.org\/10.1016\/j.jaad.2023.08.102.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1924_CR7","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/jdv.20229","volume":"38","author":"JI Silverberg","year":"2024","unstructured":"Silverberg JI, Gooderham M, Katoh N, Aoki V, Pink AE, Binamer Y, et al. Combining treat\u2010to\u2010target principles and shared decision\u2010making: international expert consensus\u2010based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis. J Eur Acad Dermatol Venereol. 2024;38(11):2139\u201348. https:\/\/doi.org\/10.1111\/jdv.20229.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1924_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/derm.2022.29015.jsi","volume":"34","author":"JI Silverberg","year":"2023","unstructured":"Silverberg JI, Mohawk JA, Cirulli J, Nograles K, Punzalan JC, Kelly KM, et al. Burden of disease and unmet needs in atopic dermatitis: results from a patient survey. Dermatitis. 2023;34(2):135\u201344. https:\/\/doi.org\/10.1089\/derm.2022.29015.jsi.","journal-title":"Dermatitis"},{"issue":"4","key":"1924_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamadermatol.2023.6245","volume":"160","author":"A Shields","year":"2024","unstructured":"Shields A, Barg FK, Begolka WS, Sage K, Druby K, Gondo GC, et al. Identifying core outcome domains in chronic skin disease using the best-worst scaling method. JAMA Dermatol. 2024;160(4):441. https:\/\/doi.org\/10.1001\/jamadermatol.2023.6245.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1924_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/derm.2022.0040","volume":"35","author":"KF Van Halewijn","year":"2024","unstructured":"Van Halewijn KF, Van Der Most F, Bohnen AM, Pasmans SGMA, Bindels PJE, Elshout G. Atopic dermatitis in children in the general population: baseline characteristics, medication use, and severity measures in the Rotterdam Eczema Study. Dermatitis. 2024;35(1):61\u20139. https:\/\/doi.org\/10.1089\/derm.2022.0040.","journal-title":"Dermatitis"},{"key":"1924_CR11","doi-asserted-by":"publisher","first-page":"adv00854","DOI":"10.2340\/actadv.v103.4426","volume":"103","author":"E Weisshaar","year":"2023","unstructured":"Weisshaar E, Bentz P, Apfelbacher C, Haufe E, Heinrich L, Heratizadeh A, et al. Itching in atopic dermatitis: patient- and physician-reported outcomes in the German Atopic Dermatitis Registry TREATgermany. Acta Derm Venereol. 2023;103:adv00854. https:\/\/doi.org\/10.2340\/actadv.v103.4426.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"1924_CR12","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/bjd\/ljae056","volume":"190","author":"EL Simpson","year":"2024","unstructured":"Simpson EL, Eckert L, Gadkari A, Brown TM, Lio PA, Lockshin B, et al. Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients\u2019 responses and clinicians\u2019 impressions of atopic dermatitis control. Br J Dermatol. 2024;190(6):917\u20139. https:\/\/doi.org\/10.1093\/bjd\/ljae056.","journal-title":"Br J Dermatol"},{"key":"1924_CR13","doi-asserted-by":"publisher","unstructured":"Silverberg JI, Gooderham M, Katoh N, Aoki V, Pink AE, Binamer Y, et al. 327 Optimizing the management of atopic dermatitis with a new minimal disease activity concept and criteria and consensus-based recommendations for systemic therapy. Br J Dermatol. 2023 Jan 25;188(Supplement_2):ljac140.022. https:\/\/doi.org\/10.1093\/bjd\/ljac140.022","DOI":"10.1093\/bjd\/ljac140.022"},{"key":"1924_CR14","doi-asserted-by":"publisher","unstructured":"Silverberg JI, Gooderham MJ, Katoh N, Aoki V, Pink AE, Binamer Y, et al. 403 Achievement of minimal disease activity is associated with improvements in symptoms, quality of life and treatment satisfaction in patients with atopic dermatitis. Br J Dermatol. 2023 Jun 20;188(Supplement_3):ljad162.026. https:\/\/doi.org\/10.1093\/bjd\/ljad162.026","DOI":"10.1093\/bjd\/ljad162.026"},{"issue":"12","key":"1924_CR15","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1007\/s13555-025-01550-8","volume":"15","author":"G Avallone","year":"2025","unstructured":"Avallone G, Bombelli A, Gargiulo L, Foti C, Trave I, Rossi M, et al. Effectiveness, safety, and health-related quality of life in moderate-to-severe atopic dermatitis treated with lebrikizumab: a 16-week nationwide retrospective cohort study. Dermatol Ther. 2025;15(12):3671\u201388. https:\/\/doi.org\/10.1007\/s13555-025-01550-8.","journal-title":"Dermatol Ther"},{"key":"1924_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.70260","author":"F Leo","year":"2026","unstructured":"Leo F, Mastorino L, Cangialosi L, Favre D, Fiasconaro CA, Liao Y, et al. Minimal disease activity as a new therapeutic target in atopic dermatitis: a 5\u2010year real\u2010life experience with dupilumab. Int J Dermatol. 2026. https:\/\/doi.org\/10.1111\/ijd.70260.","journal-title":"Int J Dermatol"},{"key":"1924_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-026-01683-4","author":"FJ Melgosa Ramos","year":"2026","unstructured":"Melgosa Ramos FJ, Guill\u00e9n Climent S, Galarreta Pascual M, Martorell A, Matellanes Palacios M, Roca Gin\u00e9s J, et al. Minimal disease activity as a therapeutic goal in atopic dermatitis: predictive factors of sustainability in a multicenter cohort. Dermatol Ther. 2026. https:\/\/doi.org\/10.1007\/s13555-026-01683-4.","journal-title":"Dermatol Ther"},{"key":"1924_CR18","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2024.0553","author":"AI Rodriguez-Sanna","year":"2025","unstructured":"Rodriguez-Sanna AI, Montero-Vilchez C, Moreno-Suarez FG, Garrido-Colmenero C, Aceituno-Madera P, Arias-Santiago S, et al. Patients with atopic dermatitis treated with upadacitinib: factors related to achieving minimal disease activity. Dermatitis. 2025. https:\/\/doi.org\/10.1089\/derm.2024.0553.","journal-title":"Dermatitis"},{"issue":"12","key":"1924_CR19","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/ced\/llae208","volume":"49","author":"S Ferrucci","year":"2024","unstructured":"Ferrucci S, Tavecchio S, Maronese CA, Balato A, Di Brizzi EV, Ortoncelli M, et al. Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients. Clin Exp Dermatol. 2024;49(12):1561\u201372. https:\/\/doi.org\/10.1093\/ced\/llae208.","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"1924_CR20","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s13555-023-01038-3","volume":"13","author":"H Penton","year":"2023","unstructured":"Penton H, Jayade S, Selveindran S, Heisen M, Piketty C, Ulianov L, et al. Assessing response in atopic dermatitis: a systematic review of the psychometric performance of measures used in HTAs and clinical trials. Dermatol Ther. 2023;13(11):2549\u201371. https:\/\/doi.org\/10.1007\/s13555-023-01038-3.","journal-title":"Dermatol Ther"},{"issue":"6","key":"1924_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s40257-017-0284-y","volume":"18","author":"W Wei","year":"2017","unstructured":"Wei W, Anderson P, Gadkari A, Blackburn S, Moon R, Piercy J, et al. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol. 2017;18(6):825\u201335. https:\/\/doi.org\/10.1007\/s40257-017-0284-y.","journal-title":"Am J Clin Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01924-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:00:49Z","timestamp":1792951249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01924-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1924"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01924-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"17 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Andrea I Rodr\u00edguez-Sanna declares no conflict of interest in relation to this study; Carmen Garc\u00eda-Moronta declares no conflict of interest in relation to this study; Julia Castro-Martin declares no conflict of interest in relation to this study; Clara A Ure\u00f1a-Paniego declares no conflict of interest in relation to this study; Salvador Arias-Santiago declares no conflict of interest in relation to this study; Trinidad Montero-Vilchez declares no conflict of interest in relation to this study.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, Spanish Biomedical Research Law 14\/2007, General Data Protection Regulation (EU) 2016\/679, and Spanish Organic Law 3\/2018 on Personal Data Protection and Guarantee of Digital Rights. The study protocol was approved by the Provincial Research Ethics Committee of Granada (CEI Granada) (approval no. SICEIA-2026-001721). All participants provided written informed consent prior to inclusion in the study. Data were anonymized prior to analysis.","order":2,"name":"Ethics","label":"Ethics Standards","group":{"name":"EthicsHeading","label":"Declarations"}}]}}